<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04531644</url>
  </required_header>
  <id_info>
    <org_study_id>CS/TD/20/05</org_study_id>
    <nct_id>NCT04531644</nct_id>
  </id_info>
  <brief_title>Double Stimulation in Women With Low Prognosis in ART</brief_title>
  <official_title>Impact of Double Stimulation (DuoStim) in Women Affected by Low Prognosis to Assisted Reproductive Technologies</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tu Du Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Federico II University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Medicine and Pharmacy at Ho Chi Minh City</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Tu Du Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main objective of this study is to compare the cumulative ongoing pregnancy rates of two&#xD;
      different IVF protocols in women candidate for ART characterized by low prognosis.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The patients will be allocated into two groups: control and study group _ In study group,&#xD;
      patients will be treated by DuoStim protocol: The first phase of ovarian stimulation is&#xD;
      started on the second day or third day of period. GnRH agonist will be used to trigger when&#xD;
      at least two follicles ≥ 17 mm. Approximately 36 hours later, oocytes will be retrieved&#xD;
      vaginally under ultrasound monitoring and ICSI will be performed. Five days later after&#xD;
      oocyte retrieval, the second stimulation will be started. All embryos will be cryopreserved.&#xD;
&#xD;
      _ In control group, patients will be treated with antagonist protocol: The cycle of ovarian&#xD;
      stimulation is started on the second day or third day of period. hCG will be used to trigger&#xD;
      when at least two follicles ≥ 17 mm. Approximately 36 hours later, oocytes will be retrieved&#xD;
      vaginally under ultrasound monitoring and ICSI will be performed. If serum progesterone on&#xD;
      the day of trigger ≥ 1.5 ng/ml, all embryos will be cryostored; otherwise, fresh embryos will&#xD;
      be transferred.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 14, 2020</start_date>
  <completion_date type="Anticipated">November 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">August 30, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cumulative Ongoing pregnancy rate</measure>
    <time_frame>week 11 - 14 of pregnancy</time_frame>
    <description>calculated by the number of ongoing pregnancy patients divided by the total number of patients in appropriate group</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pregnancy rate</measure>
    <time_frame>2 weeks after embryo transfer</time_frame>
    <description>beta-hCG test is positive</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ongoing pregnancy rate</measure>
    <time_frame>week 11 - 14 of pregnancy</time_frame>
    <description>defined as the pregnancy completed 11 - 14 weeks of gestation and having vital fetus</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of oocytes retrieved</measure>
    <time_frame>4 hours after occyte pick-up</time_frame>
    <description>Number of oocytes retrieved identified by the embryologists</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of mature oocytes</measure>
    <time_frame>4 hours after oocyte pick-up</time_frame>
    <description>Number of mature oocytes identified by the embryologists</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of competent embryos</measure>
    <time_frame>3 days to 5 days after oocyte pick-up</time_frame>
    <description>Number of embryos that can be transferred</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fertilization rate</measure>
    <time_frame>1 to 3 days after oocyte pick-up</time_frame>
    <description>number of fertilized oocyted divided by number of mature oocytes</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Assisted Reproductive Techniques</condition>
  <arm_group>
    <arm_group_label>Study</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>the patients in this group will be treated with double stimulation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>the patients in this group will be treated with conventional ovarian stimulation</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>double stimulation</intervention_name>
    <description>the patients will be treated with two consecutive ovarian stimulations in one cycle</description>
    <arm_group_label>Study</arm_group_label>
    <other_name>DuoStim</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>conventional ovarian stimulation</intervention_name>
    <description>the patients will be treated with one conventional ovarian stimulation in one cycle</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age ≤ 40.&#xD;
&#xD;
          -  AMH ≥ 0.3 ng/ml and ≤ 1.2 ng/ml.&#xD;
&#xD;
          -  OR 3 ≤ AFC ≤7.&#xD;
&#xD;
          -  Normal shape of uterus (based on ultrasound).&#xD;
&#xD;
          -  Body mass index within 28 - 37 kg/m2&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Asherman's syndrome.&#xD;
&#xD;
          -  Endometriosis.&#xD;
&#xD;
          -  Leiomyomas distorting the endometrium&#xD;
&#xD;
          -  Sperm extracted from surgical procedures (i.e. PESA, TESE).&#xD;
&#xD;
          -  Patients refuse to continue participating in the study.&#xD;
&#xD;
          -  Patients injected with wrong dose of gonadotropins during the treatment.&#xD;
&#xD;
          -  Serious complications or accidents arise forcing the patients to discontinue the&#xD;
             treatments.&#xD;
&#xD;
          -  Ovarian surgery&#xD;
&#xD;
          -  Previous chemotherapy or pelvic irradiation&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chau TM Le, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Tu Du Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Chau TM Le, PhD</last_name>
    <phone>+84908429006</phone>
    <email>dr.lethiminhchau@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Anh Q Nguyen, Master</last_name>
    <phone>+84976137562</phone>
    <email>dr.anhquocnguyen@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Infertility of Tu Du hospital</name>
      <address>
        <city>Ho Chi Minh City</city>
        <zip>70000</zip>
        <country>Vietnam</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chau TM Le, PhD</last_name>
      <phone>0084908429006</phone>
      <email>dr.lethiminhchau@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Anh Q Nguyen, MMSc</last_name>
      <phone>0084976137562</phone>
      <email>dr.anhquocnguyen@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Tu K Duong, MMSc</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Vietnam</country>
  </location_countries>
  <results_reference>
    <citation>Cardoso MCA, Evangelista A, Sartório C, Vaz G, Werneck CLV, Guimarães FM, Sá PG, Erthal MC. Can ovarian double-stimulation in the same menstrual cycle improve IVF outcomes? JBRA Assist Reprod. 2017 Sep 1;21(3):217-221. doi: 10.5935/1518-0557.20170042.</citation>
    <PMID>28837031</PMID>
  </results_reference>
  <results_reference>
    <citation>Kuang Y, Chen Q, Hong Q, Lyu Q, Ai A, Fu Y, Shoham Z. Double stimulations during the follicular and luteal phases of poor responders in IVF/ICSI programmes (Shanghai protocol). Reprod Biomed Online. 2014 Dec;29(6):684-91. doi: 10.1016/j.rbmo.2014.08.009. Epub 2014 Sep 6.</citation>
    <PMID>25444501</PMID>
  </results_reference>
  <results_reference>
    <citation>Poseidon Group (Patient-Oriented Strategies Encompassing IndividualizeD Oocyte Number), Alviggi C, Andersen CY, Buehler K, Conforti A, De Placido G, Esteves SC, Fischer R, Galliano D, Polyzos NP, Sunkara SK, Ubaldi FM, Humaidan P. A new more detailed stratification of low responders to ovarian stimulation: from a poor ovarian response to a low prognosis concept. Fertil Steril. 2016 Jun;105(6):1452-3. doi: 10.1016/j.fertnstert.2016.02.005. Epub 2016 Feb 26.</citation>
    <PMID>26921622</PMID>
  </results_reference>
  <results_reference>
    <citation>Ubaldi FM, Capalbo A, Vaiarelli A, Cimadomo D, Colamaria S, Alviggi C, Trabucco E, Venturella R, Vajta G, Rienzi L. Follicular versus luteal phase ovarian stimulation during the same menstrual cycle (DuoStim) in a reduced ovarian reserve population results in a similar euploid blastocyst formation rate: new insight in ovarian reserve exploitation. Fertil Steril. 2016 Jun;105(6):1488-1495.e1. doi: 10.1016/j.fertnstert.2016.03.002. Epub 2016 Mar 25.</citation>
    <PMID>27020168</PMID>
  </results_reference>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>August 18, 2020</study_first_submitted>
  <study_first_submitted_qc>August 26, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 28, 2020</study_first_posted>
  <last_update_submitted>September 12, 2021</last_update_submitted>
  <last_update_submitted_qc>September 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 14, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Tu Du Hospital</investigator_affiliation>
    <investigator_full_name>Le Thi Minh Chau</investigator_full_name>
    <investigator_title>Head of department of Infertility</investigator_title>
  </responsible_party>
  <keyword>double ovarian stimulation</keyword>
  <keyword>low prognosis women</keyword>
  <keyword>ongoing pregnancy</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

